Historical Valuation
Advanced Biomed Inc (ADVB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Advanced Biomed Inc (ADVB) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.36
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Advanced Biomed Inc (ADVB) has a current Price-to-Book (P/B) ratio of 2.18. Compared to its 3-year average P/B ratio of 13.75 , the current P/B ratio is approximately -84.17% higher. Relative to its 5-year average P/B ratio of 13.75, the current P/B ratio is about -84.17% higher. Advanced Biomed Inc (ADVB) has a Forward Free Cash Flow (FCF) yield of approximately -98.19%. Compared to its 3-year average FCF yield of -41.92%, the current FCF yield is approximately 134.26% lower. Relative to its 5-year average FCF yield of -41.92% , the current FCF yield is about 134.26% lower.
P/B
Median3y
13.75
Median5y
13.75
FCF Yield
Median3y
-41.92
Median5y
-41.92
Competitors Valuation Multiple
AI Analysis for ADVB
The average P/S ratio for ADVB competitors is 11.03, providing a benchmark for relative valuation. Advanced Biomed Inc Corp (ADVB.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for ADVB
1Y
3Y
5Y
Market capitalization of ADVB increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ADVB in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ADVB currently overvalued or undervalued?
Advanced Biomed Inc (ADVB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Advanced Biomed Inc (ADVB) is between to according to relative valuation methord.
What is Advanced Biomed Inc (ADVB) fair value?
ADVB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Advanced Biomed Inc (ADVB) is between to according to relative valuation methord.
How does ADVB's valuation metrics compare to the industry average?
The average P/S ratio for ADVB's competitors is 11.03, providing a benchmark for relative valuation. Advanced Biomed Inc Corp (ADVB) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Advanced Biomed Inc (ADVB) as of Jan 10 2026?
As of Jan 10 2026, Advanced Biomed Inc (ADVB) has a P/B ratio of 2.18. This indicates that the market values ADVB at 2.18 times its book value.
What is the current FCF Yield for Advanced Biomed Inc (ADVB) as of Jan 10 2026?
As of Jan 10 2026, Advanced Biomed Inc (ADVB) has a FCF Yield of -98.19%. This means that for every dollar of Advanced Biomed Inc’s market capitalization, the company generates -98.19 cents in free cash flow.
What is the current Forward P/E ratio for Advanced Biomed Inc (ADVB) as of Jan 10 2026?
As of Jan 10 2026, Advanced Biomed Inc (ADVB) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Advanced Biomed Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Advanced Biomed Inc (ADVB) as of Jan 10 2026?
As of Jan 10 2026, Advanced Biomed Inc (ADVB) has a Forward P/S ratio of 0.00. This means the market is valuing ADVB at $0.00 for every dollar of expected revenue over the next 12 months.